White Papers Archive | Page 2 of 6 | Premier Research

Mapping the New Landscape of Orphan Drug Development

Six Dosing and Safety Considerations in the Era of Emerging Therapies

Safety, Efficacy, Cost: The Trifecta for Increasing Access to CAR-T Therapies

Continue this conversation with a Premier expert

Learn more about our Gene Therapy strategic capabilities.

Driving Product Development and Finding the Fast Track in Early-Phase Oncology Programs

Making the Switch from Rx to OTC

Making the Asia-Pacific Region a Destination of Choice for Oncology Clinical Trials

Why More Drugs Than Ever Are Approved Through 505(b)(2)

Why 505(b)(2) is a Whole Different Animal

Natural History Studies: Understanding and Enhancing Their Value in Rare Diseases

Addressing the Challenges and Opportunities in Gynecologic Cancer Research

First
←
2
3
4
→
Last